Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

Clinical trial NCT03209518 · COMPLETED

Trial details

NCT number: NCT03209518
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Premenopausal Breast Cancer

Start date: 2016-03-18
Primary completion: 2018-10-10
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.